TRENDS AND CAUSES OF CONGENITAL ANOMALIES IN THE PLEVEN REGION, BULGARIA
Kovacheva K1*, Simeonova M1, Velkova A2
*Corresponding Author: Katya Kovacheva, MD, Assistant Professor, Department of Medical Genetics, Medical University, 1, Kliment Ohridski str., Pleven 5800, Bulgaria; Tel.: +359-6488-4169; Fax: +359-6482-2667; E-mail: katiakovach@gmail.com
page: 37

RESULTS

During the study period (1988-2006), a total of 1,225 cases (1,115 live births, 72 stillbirths and 38 terminations of pregnancy) with CAs were ascertained. Table 1 presents the total number of CAs, the total, and live birth prevalence. The overall total prevalence of CAs was 25.72 (95% CI 24.3 to 27.15) per 1,000 births over the study period. There was a significant increase in total prevalence from 17.76 (95% CI 13.45 to 22.07) per 1,000 births in 1988 to 29.40 (95% CI 22.41 to 36.39) in 2006 (c2 = 5.03; p = 0.025). There were 47,229 live births and 1,115 live births with CAs, giving an overall live birth prevalence of 23.61 (95% CI 22.24 to 24.98) per 1,000 live births. There was a significant increase in live birth prevalence from 16.45 (95% CI 12.29 to 20.62) per 1,000 live births in 1988 to 26.18 (95% CI 19.53 to 32.84) in 2006 (c2 = 4.27; p = 0.039).

Table 2 summarizes the main types of CA; number, proportion (% of all cases registered) and prevalence (per 1,000 registered births). Higher rates were notified for CHD (4.3 per 1,000), all nervous system CAs (3.3 per 1,000), limb defects (2.5 per 1,000). Neural tube defects showed a total prevalence of 2.0 per 1,000 per registered births, and about 20% of all cases of this defect resulted in termination of pregnancy. Most of the CHD cases (80%) were ascertained in the nenonatal period of live born babies or in stillbirths (based on active screening). About 20% of the cases were diagnosed in the post neonatal period up to the end of the first year of life of the babies (some cases were identified via case records from the Department of Pediatrics, University Hospital, Pleven, Bulgaria).

The total prevalence of most CAs remained stable over the study period. However, there was a trend towards a significant increase in the total prevalence of specific anomalies: digestive system anomalies (c2 = 4.48; p = 0.034), tumors (mostly teratomas) (c2 = 4.98; p = 0.026), musculoskeletal and connective tissue anomalies (mainly gastroschisis) (c2 = 5.52; p = 0.019), non syndromal dysmorphologic conditions (c2 = 6.77; p = 0.009).

Table 3 summarizes the main causes of registered CAs, number of cases, proportion (% of all cases registered) and prevalence (per 1,000 registered births). The most common CAs were those due to genetic causes (chromosomal, single gene, multifactorial), with a total prevalence of 15.8 per 1,000 registered births over the study period.




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006